Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Dec 2017 – 20 Aug 2026, limited by Groww ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 29 Dec 2017 | ₹100.00 | ₹100.00 |
| 18 Sep 2018 | ₹95.22 | ₹101.09 |
| 08 Jun 2019 | ₹97.91 | ₹102.58 |
| 26 Feb 2020 | ₹98.11 | ₹101.39 |
| 15 Nov 2020 | ₹101.69 | ₹109.45 |
| 05 Aug 2021 | ₹126.59 | ₹147.32 |
| 25 Apr 2022 | ₹127.59 | ₹154.60 |
| 13 Jan 2023 | ₹134.86 | ₹161.70 |
| 03 Oct 2023 | ₹149.40 | ₹181.80 |
| 22 Jun 2024 | ₹196.51 | ₹234.30 |
| 12 Mar 2025 | ₹171.71 | ₹213.52 |
| 30 Nov 2025 | ₹201.69 | ₹252.18 |
| 20 Aug 2026 | ₹191.43 | ₹247.75 |
| Metric | Groww · Regular · IDCW NAV ₹19.22 Very High risk ★★★☆☆ | Category median ELSS · 66 funds |
|---|---|---|
| -5.13% | +1.19% | |
| +10.11% | +8.64% | |
| +8.80% | +7.82% | |
| — | +9.60% | |
| +7.80% | +8.99% | |
| +7.19% | — | |
| +12.99% | +10.48% | |
| +12.62% | +10.98% | |
| — | +8.21% | |
| Risk | ||
| 14.38% | 14.15% | |
| 0.25 | 0.21 | |
| 0.34 | 0.29 | |
| -35.90% | -39.29% | |
| Nifty 500 | — | |
| -1.52% | -2.44% | |
| 0.96 | 0.95 | |
| 94.0% | 85.5% | |
| 101.6% | 95.8% | |
| 2.85% | 2.37% | |
| ₹45.94Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 48% | 34% | |
| Nikhil Satam | — | |
| 29 Dec 2017 | — | |
| 64 | — | |
| 36.4% | — | |
| 3.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.